Biocept offers circulating tumor cell (CTC) capture and enumeration along with molecular analysis for genomic profiling. Our current test offering includes CTC plus Her2 testing.
Biocept consistently captures circulating tumor cells (CTCs) in patients with early-stage, metastatic or recurrent cancer. We offer laboratory tests for Enumeration and HER2 (FISH).
Biocept has entered into collaborations with several academic institutions and pharmaceutical or biotech companies to explore the application of the CEE system to research CTCs.